Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate

World Journal of Gastroenterology

Volumn 19, Issue 27, 2013, Pages 4356-4362

  Wiernicka, Anna ^a   Jańczyk, Wojciech ^a   Dadalski, Maciej ^a   Avsar, Yesim ^b   Schmidt, Hartmut ^b   Socha, Piotr ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Abdominal pain; Gastrointestinal ulcer; Therapy; Wilson's disease; Zinc

Indexed keywords

PENICILLAMINE; PROTON PUMP INHIBITOR; WILSON DISEASE PROTEIN; ZINC ACETATE; ZINC SULFATE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CHILD; DIGESTIVE SYSTEM ULCER; EROSION; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRESCHOOL CHILD; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; VOMITING; WILSON DISEASE;

EID: 84880444259     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i27.4356     Document Type: Article

References (30)

1. Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990; 51: 225-227 [PMID: 2407097]
2. Hoffman HN, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterology 1988; 94: 508-512 [PMID: 3335323]
3. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA 1990; 264: 1441-1443 [PMID: 2094240]
4. Yuzbasiyan-Gurkan V, Brewer GJ, Abrams GD, Main B, Giacherio D. Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease. J Lab Clin Med 1989; 114: 520-526 [PMID: 2478644]
5. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V. Treatment of Wilson's disease with zinc. IX: Response of serum lipids. J Lab Clin Med 1991; 118: 466-470 [PMID: 1940587]
6. Brewer GJ, Johnson V, Kaplan J. Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function. J Lab Clin Med 1997; 129: 649-652 [PMID: 9178732 DOI: 10.1016/S0022-2143(97)90200-6]
7. Wiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009; 29: 947-958 [PMID: 19210288 DOI: 10.1111/ j.1365-2036.2009.03959.x]
8. Lapere D, Gottrand F, Debray D, Bridoux-Henno L, Lachaux A, Morali A, Lamireau T. Efficacy and tolerance of zinc in the treatment of Wilson disease. Proceedings of European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Annual Meeting; 2010 Jun 9-12; Istanbul, Turkey. J Pediatr Gastroenterol Nutr 2010; 50 (Suppl 2): E154-E155
9. Linn FH, Houwen RH, van Hattum J, van der Kleij S, van Erpecum KJ. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology 2009; 50: 1442-1452 [PMID: 19731238 DOI: 10.1002/hep.23182]
10. Mizuochi T, Kimura A, Shimizu N, Nishiura H, Matsushita M, Yoshino M. Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease. J Pediatr Gastroenterol Nutr 2011; 53: 365-367 [PMID: 21970993 DOI: 10.1097/MPG.0b013e31821d5abe]
11. Abdel Ghaffar TY, Elsayed SM, Elnaghy S, Shadeed A, Elsobky ES, Schmidt H. Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients. BMC Pediatr 2011; 11: 56 [PMID: 21682854 DOI: 10.1186/1471-2431-11-56]
12. Wang LC, Wang JD, Tsai CR, Cheng SB, Lin CC. Clinical features and therapeutic response in Taiwanese children with Wilson's disease: 12 years of experience in a single center. Pediatr Neonatol 2010; 51: 124-129 [PMID: 20417464 DOI: 10.1016/S1875-9572(10)60022-8]
13. 8th International Conference on Wilson Disease and Menkes Disease. Leipzig, Germany, April 16-18, 2001. Abstracts. Z Gastroenterol 2001; 39: 245-260 [PMID: 11444216]
14. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23: 139-142 [PMID: 12955875]
15. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV longterm follow-up studies. J Lab Clin Med 1998; 132: 264-278 [PMID: 9794697 DOI: 10.1016/S0022-2143(98)90039-7]
16. Medici V, Rossaro L, Sturniolo GC. Wilson disease--a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis 2007; 39: 601-609 [PMID: 17382611 DOI: 10.1016/ j.dld.2006.12.095]
17. Medici V, Trevisan CP, D'Incà R, Barollo M, Zancan L, Fagiuoli S, Martines D, Irato P, Sturniolo GC. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 2006; 40: 936-941 [PMID: 17063115]
18. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003; 37: 1475-1492 [PMID: 12774027 DOI: 10.1053/jhep.2003.50252]
19. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47: 2089-2111 [PMID: 18506894 DOI: 10.1002/hep.22261]
20. Brewer GJ, Dick RD, Johnson VD, Fink JK, Kluin KJ, Daniels S. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med 2001; 137: 191-198 [PMID: 11241029 DOI: 10.1067/mlc.2001.113037]
21. Pecoud A, Dozel F, Schelling JL. The effect of foodstuffs on the absorption of zinc sulfate. Clin Pharmacol Ther 1975; 17: 469-474 [PMID: 1091398]
22. Bruha R, Marecek Z, Pospisilova L, Nevsimalova S, Vitek L, Martasek P, Nevoral J, Petrtyl J, Urbanek P, Jiraskova A, Ferenci P. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int 2011; 31: 83-91 [PMID: 20958917 DOI: 10.1111/j.1478-3231.2010.02354.x]
23. Shimizu N, Fujiwara J, Ohnishi S, Sato M, Kodama H, Kohsaka T, Inui A, Fujisawa T, Tamai H, Ida S, Itoh S, Ito M, Horiike N, Harada M, Yoshino M, Aoki T. Effects of longterm zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism. Transl Res 2010; 156: 350-357 [PMID: 21078496 DOI: 10.1016/j.trsl.2010.08.007]
24. Czlonkowska A, Gajda J, Rodo M. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. J Neurol 1996; 243: 269-273 [PMID: 8936358]
25. Moore R. Bleeding gastric erosion after oral zinc sulphate. Br Med J 1978; 1: 754 [PMID: 147123 DOI: 10.1136/ bmj.1.6115.754]
26. Molokhia MM, Portnoy B. Bleeding gastric erosion after oral zinc sulphate. Br Med J 1978; 1: 1145 [PMID: 305805 DOI: 10.1136/bmj.1.6120.1145]
27. Sulllivan PB. Peptic ulcer disease in children. Paediatrics and Child Health 2010; 10: 462-464 [DOI: 10.1016/ j.paed.2010.04.002]
28. Sultz HA, Schlesinger ER, Feldman JG, Mosher WE. The epidemiology of peptic ulcer in childhood. Am J Public Health Nations Health 1970; 60: 492-498 [PMID: 5461528 DOI: 10.2105/AJPH.60.3.492]
29. Masełbas W, Chabik G, Członkowska A. Persistence with treatment in patients with Wilson disease. Neurol Neurochir Pol 2010; 44: 260-263 [PMID: 20625962]
30. Walshe JM. Cause of death in Wilson disease. Mov Disord 2007; 22: 2216-2220 [PMID: 17712859 DOI: 10.1002/mds.21693]